Publications by authors named "Andrew Fluxe"

Claim this Profile
E
Evolution of thiazolidine-based blockers of human Kv1.5 for the treatment of atrial arrhythmias.
Chris M Jackson, Benjamin Blass, Keith Coburn, Laurent Djandjighian, Gina Fadayel, Andrew J Fluxe

Bioorg Med Chem Lett· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery and in vitro/in vivo studies of tetrazole derivatives as Kv1.5 blockers.
Shengde Wu, Andrew Fluxe, Jim Sheffer, John M Janusz, Benjamin E Blass

Bioorg Med Chem Lett· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery and synthesis of tetrahydroindolone derived semicarbazones as selective Kv1.5 blockers.
Shengde Wu, Andrew Fluxe, John M Janusz, James B Sheffer, Greg Browning

Bioorg Med Chem Lett· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery and synthesis of tetrahydroindolone-derived carbamates as Kv1.5 blockers.
Andrew Fluxe, Shengde Wu, James B Sheffer, John M Janusz, Michael Murawsky

Bioorg Med Chem Lett· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and evaluation of (2-phenethyl-2H-1,2,3-triazol-4-yl)(phenyl)methanones as Kv1.5 channel blockers for the treatment of atrial fibrillation.
Benjamin E Blass, Keith Coburn, Wenlin Lee, Neil Fairweather, Andrew Fluxe

Bioorg Med Chem Lett· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis